AVE Insider Trading (Avecho Biotechnology)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Avecho Biotechnology Insider Trading History Chart

This chart shows the insider buying and selling history at Avecho Biotechnology by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Avecho Biotechnology Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 06/1/2021 01:08 PM ET

This chart shows the closing price history over time for AVE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Avecho Biotechnology Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/10/2021Gregory (Greg) CollierInsiderExpiry2,250,000A$0.02A$40,500.00
5/31/2021Matthew McNamaraInsiderIssued3,993,644A$0.02A$75,879.24
See Full Table

SEC Filings (Institutional Ownership Changes) for Avecho Biotechnology (ASX:AVE)

Avecho Biotechnology logo
Avecho Biotechnology Limited, a biotechnology company, develops, produces, and sells products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, skin care, animal health, and nutrition industries. It offers TPM and Vital ET products for use in drug delivery and cosmetic formulations; and develops TPM/Oxymorphone and TPM/Oxycodone. The company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. It also provides non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company has a collaboration with Lambert Initiative at the University of Sydney to conduct a study to examine whether topically applied cannabidiol can provide relief from symptoms of osteoarthritis. It serves customers in Australia, Switzerland, India, and internationally. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia.
Read More on Avecho Biotechnology

Today's Range

Now: N/A

50 Day Range


52 Week Range

Now: N/A



Average Volume


Market Capitalization


P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Avecho Biotechnology?

Avecho Biotechnology's top insider investors include:
  1. Gregory (Greg) Collier (Insider)
  2. Matthew McNamara (Insider)
Learn More about top insider investors at Avecho Biotechnology.